Qiming-backed biotech Oricell raises $70m Series C1 round

Qiming-backed biotech Oricell raises $70m Series C1 round

Normal cells of human connective tissue in culture at a magnification of 500x. Photo by National Cancer Institute on Unsplash

12 January, 2026

Edited by: Padma Priya

biotech cell therapies commercialisation immunology Oncology Ori-C101 OriCell Therapeutics

Printed by Unregistered user on Sat, 14 Feb 2026 03:37:52 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Temasek's ClavystBio bets on AI to generate 2-3x returns from biotech

Venture Capital

Italy's Angelini Ventures opens SG office to grow Asia biotech portfolio

Read more from Greater China

ByteDance in talks to sell gaming unit Moonton for over $6b

Policy & Regulations

China says semiconductor supply chain stability top priority after Dutch ruling on Nexperia